Finally, an in silico genetic comparison of SYK with known tumour suppressor genes such as TP53 and PTEN across a number of breast cancer databases revealed no evidence that SYK has a typical tumour suppressor gene profile such as focal deletion, inactivating mutations or in-frame mutations. This evidence concerns the gene TP53 and breast carcinoma.